| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclosporin A binding | 1.19e-10 | 24 | 128 | 7 | GO:0016018 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.99e-08 | 50 | 128 | 7 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 4.55e-08 | 53 | 128 | 7 | GO:0016859 | |
| GeneOntologyMolecularFunction | isomerase activity | 2.42e-04 | 192 | 128 | 7 | GO:0016853 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 3.41e-09 | 38 | 129 | 7 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 4.41e-08 | 54 | 129 | 7 | GO:0018208 | |
| GeneOntologyBiologicalProcess | endocytic hemoglobin import into cell | 3.88e-05 | 2 | 129 | 2 | GO:0020028 | |
| GeneOntologyCellularComponent | hemidesmosome | 3.83e-05 | 11 | 131 | 3 | GO:0030056 | |
| HumanPheno | Linear nevus sebaceous | 6.89e-07 | 3 | 46 | 3 | HP:0010817 | |
| HumanPheno | Nevus sebaceous | 6.81e-06 | 5 | 46 | 3 | HP:0010815 | |
| HumanPheno | Congenital giant melanocytic nevus | 2.35e-05 | 7 | 46 | 3 | HP:0005600 | |
| HumanPheno | Abnormal esophagus morphology | CACNA2D1 FLNC BRIP1 TBX4 LAMA3 ITGA6 RFC2 FANCM DDB1 ZEB2 SLC44A1 FBN2 DST ALMS1 GUCY1A1 GLRA1 VPS35L HRAS PKHD1 ARHGAP29 COL14A1 GRHL3 | 4.80e-05 | 1078 | 46 | 22 | HP:0002031 |
| HumanPheno | Hypophosphatemic rickets | 6.41e-05 | 25 | 46 | 4 | HP:0004912 | |
| HumanPheno | Melanoma | 7.05e-05 | 80 | 46 | 6 | HP:0002861 | |
| HumanPheno | Abnormal dermoepidermal hemidesmosome morphology | 1.08e-04 | 11 | 46 | 3 | HP:0032449 | |
| HumanPheno | Abnormal dermoepidermal junction morphology | 1.43e-04 | 12 | 46 | 3 | HP:0031538 | |
| HumanPheno | Epidermal nevus | 1.43e-04 | 12 | 46 | 3 | HP:0010816 | |
| HumanPheno | Basal cell carcinoma | 1.54e-04 | 58 | 46 | 5 | HP:0002671 | |
| Domain | Cyclophilin-type_PPIase_CS | 2.11e-09 | 19 | 126 | 6 | IPR020892 | |
| Domain | Cyclophilin-type_PPIase | 4.18e-09 | 21 | 126 | 6 | IPR024936 | |
| Domain | Pro_isomerase | 5.71e-09 | 22 | 126 | 6 | PF00160 | |
| Domain | Cyclophilin-type_PPIase_dom | 5.71e-09 | 22 | 126 | 6 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 5.71e-09 | 22 | 126 | 6 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 5.71e-09 | 22 | 126 | 6 | PS50072 | |
| Domain | - | 5.71e-09 | 22 | 126 | 6 | 2.40.100.10 | |
| Domain | CSA_PPIASE_1 | 5.71e-09 | 22 | 126 | 6 | PS00170 | |
| Domain | VWA | 3.74e-05 | 56 | 126 | 5 | PF00092 | |
| Domain | VWF_A | 5.61e-05 | 99 | 126 | 6 | IPR002035 | |
| Domain | Growth_fac_rcpt_ | 9.12e-05 | 156 | 126 | 7 | IPR009030 | |
| Domain | - | 1.43e-04 | 74 | 126 | 5 | 3.40.50.410 | |
| Domain | EGF | 1.96e-04 | 235 | 126 | 8 | SM00181 | |
| Domain | VWFA | 2.32e-04 | 82 | 126 | 5 | PS50234 | |
| Domain | VWA | 2.60e-04 | 84 | 126 | 5 | SM00327 | |
| Domain | VDCC_a2/dsu | 2.69e-04 | 4 | 126 | 2 | IPR013680 | |
| Domain | VGCC_alpha2 | 2.69e-04 | 4 | 126 | 2 | PF08473 | |
| Domain | EGF-like_dom | 2.90e-04 | 249 | 126 | 8 | IPR000742 | |
| Domain | EGF_CA | 2.90e-04 | 86 | 126 | 5 | PF07645 | |
| Domain | VWA_N | 4.46e-04 | 5 | 126 | 2 | IPR013608 | |
| Domain | VWA_N | 4.46e-04 | 5 | 126 | 2 | PF08399 | |
| Domain | EGF_Ca-bd_CS | 5.07e-04 | 97 | 126 | 5 | IPR018097 | |
| Domain | EGF_CA | 5.56e-04 | 99 | 126 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.82e-04 | 100 | 126 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.59e-04 | 106 | 126 | 5 | IPR000152 | |
| Domain | CH | 9.73e-04 | 65 | 126 | 4 | SM00033 | |
| Domain | EGF_3 | 1.09e-03 | 235 | 126 | 7 | PS50026 | |
| Domain | VWA_3 | 1.23e-03 | 8 | 126 | 2 | PF13768 | |
| Domain | - | 1.23e-03 | 8 | 126 | 2 | 2.60.40.360 | |
| Domain | CH | 1.28e-03 | 70 | 126 | 4 | PF00307 | |
| Domain | - | 1.35e-03 | 71 | 126 | 4 | 1.10.418.10 | |
| Domain | EGF_CA | 1.43e-03 | 122 | 126 | 5 | SM00179 | |
| Domain | CH | 1.50e-03 | 73 | 126 | 4 | PS50021 | |
| Domain | EGF-like_Ca-bd_dom | 1.53e-03 | 124 | 126 | 5 | IPR001881 | |
| Domain | GPS | 1.54e-03 | 34 | 126 | 3 | SM00303 | |
| Domain | PapD-like | 1.58e-03 | 9 | 126 | 2 | IPR008962 | |
| Domain | FN3 | 1.61e-03 | 185 | 126 | 6 | SM00060 | |
| Domain | CH-domain | 1.66e-03 | 75 | 126 | 4 | IPR001715 | |
| Domain | RAS | 1.68e-03 | 35 | 126 | 3 | PS51421 | |
| Domain | GPS | 1.68e-03 | 35 | 126 | 3 | PF01825 | |
| Domain | EGF_1 | 1.73e-03 | 255 | 126 | 7 | PS00022 | |
| Domain | GPS | 1.82e-03 | 36 | 126 | 3 | PS50221 | |
| Domain | Small_GTPase_Ras | 1.97e-03 | 37 | 126 | 3 | IPR020849 | |
| Domain | GPS | 1.97e-03 | 37 | 126 | 3 | IPR000203 | |
| Domain | EGF-like_CS | 1.98e-03 | 261 | 126 | 7 | IPR013032 | |
| Domain | - | ZNF823 ZNF397 ZNF236 ZEB2 ZNF7 ZNF22 ZNF600 ZNF732 ZNF589 ZNF286B ZNF454 ZNF433 | 2.15e-03 | 679 | 126 | 12 | 3.30.160.60 |
| Domain | EGF_2 | 2.15e-03 | 265 | 126 | 7 | PS01186 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF823 ZNF397 ZNF236 ZEB2 ZNF702P ZNF7 ZNF22 ZNF600 ZNF732 ZNF589 ZNF286B ZNF454 ZNF433 | 2.23e-03 | 775 | 126 | 13 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF823 ZNF397 ZNF236 ZEB2 ZNF702P ZNF7 ZNF22 ZNF600 ZNF732 ZNF589 ZNF286B ZNF454 ZNF433 | 2.28e-03 | 777 | 126 | 13 | PS00028 |
| Domain | zf-C2H2 | ZNF823 ZNF397 ZNF236 ZNF702P ZNF7 ZNF22 ZNF600 ZNF732 ZNF589 ZNF286B ZNF454 ZNF433 | 2.54e-03 | 693 | 126 | 12 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF823 ZNF397 ZNF236 ZEB2 ZNF7 ZNF22 ZNF600 ZNF732 ZNF589 ZNF286B ZNF454 ZNF433 | 2.57e-03 | 694 | 126 | 12 | IPR013087 |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 2.84e-06 | 5 | 94 | 3 | M26921 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 4.13e-06 | 17 | 94 | 4 | M27918 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 5.66e-06 | 6 | 94 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 5.66e-06 | 6 | 94 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 5.66e-06 | 6 | 94 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 5.66e-06 | 6 | 94 | 3 | M47932 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 9.86e-06 | 7 | 94 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 9.86e-06 | 7 | 94 | 3 | M19489 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 1.57e-05 | 8 | 94 | 3 | M47935 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 1.57e-05 | 8 | 94 | 3 | M27919 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 2.34e-05 | 9 | 94 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 2.34e-05 | 9 | 94 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 2.34e-05 | 9 | 94 | 3 | M27904 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 4.56e-05 | 11 | 94 | 3 | M27740 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 4.56e-05 | 11 | 94 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.56e-05 | 11 | 94 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.56e-05 | 11 | 94 | 3 | M47371 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 4.56e-05 | 11 | 94 | 3 | M27372 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 4.56e-05 | 11 | 94 | 3 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 4.56e-05 | 11 | 94 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 4.56e-05 | 11 | 94 | 3 | M47432 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 4.56e-05 | 11 | 94 | 3 | M27911 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 5.78e-05 | 32 | 94 | 4 | M39445 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 6.05e-05 | 12 | 94 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 6.05e-05 | 12 | 94 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 6.05e-05 | 12 | 94 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 6.05e-05 | 12 | 94 | 3 | M39408 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 7.82e-05 | 13 | 94 | 3 | M47594 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 7.82e-05 | 13 | 94 | 3 | M1441 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 9.91e-05 | 14 | 94 | 3 | M27734 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 9.91e-05 | 14 | 94 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 9.91e-05 | 14 | 94 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 9.91e-05 | 14 | 94 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 9.91e-05 | 14 | 94 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 9.91e-05 | 14 | 94 | 3 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 9.91e-05 | 14 | 94 | 3 | M569 | |
| Pathway | PID_TCR_RAS_PATHWAY | 9.91e-05 | 14 | 94 | 3 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 9.91e-05 | 14 | 94 | 3 | M47488 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 9.91e-05 | 14 | 94 | 3 | M27908 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 9.91e-05 | 14 | 94 | 3 | M719 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 1.23e-04 | 15 | 94 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.23e-04 | 15 | 94 | 3 | M47531 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.24e-04 | 73 | 94 | 5 | MM15126 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 1.28e-04 | 39 | 94 | 4 | M39905 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.29e-04 | 117 | 94 | 6 | M19248 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.51e-04 | 16 | 94 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.51e-04 | 16 | 94 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.51e-04 | 16 | 94 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 1.51e-04 | 16 | 94 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 1.51e-04 | 16 | 94 | 3 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 1.51e-04 | 16 | 94 | 3 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 1.51e-04 | 16 | 94 | 3 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 1.51e-04 | 16 | 94 | 3 | M47483 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.51e-04 | 16 | 94 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 1.51e-04 | 16 | 94 | 3 | M47682 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.82e-04 | 17 | 94 | 3 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 1.82e-04 | 17 | 94 | 3 | M47684 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 2.18e-04 | 18 | 94 | 3 | M27518 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 2.18e-04 | 18 | 94 | 3 | M39737 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 2.18e-04 | 18 | 94 | 3 | M657 | |
| Pathway | REACTOME_TIE2_SIGNALING | 2.18e-04 | 18 | 94 | 3 | M11932 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 2.57e-04 | 19 | 94 | 3 | M47793 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 2.57e-04 | 19 | 94 | 3 | M559 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 2.57e-04 | 19 | 94 | 3 | M27423 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 2.57e-04 | 19 | 94 | 3 | M41732 | |
| Pathway | PID_FANCONI_PATHWAY | 2.66e-04 | 47 | 94 | 4 | M1 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 3.01e-04 | 20 | 94 | 3 | M12256 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 3.01e-04 | 20 | 94 | 3 | M27519 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 3.01e-04 | 20 | 94 | 3 | M27524 | |
| Pathway | WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING | 3.01e-04 | 20 | 94 | 3 | M39485 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE | 3.01e-04 | 20 | 94 | 3 | M29849 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 3.01e-04 | 20 | 94 | 3 | M17670 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 3.01e-04 | 20 | 94 | 3 | M39002 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 3.50e-04 | 21 | 94 | 3 | M27511 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 3.50e-04 | 21 | 94 | 3 | M47792 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 3.50e-04 | 21 | 94 | 3 | M27485 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 4.03e-04 | 22 | 94 | 3 | M27522 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 4.03e-04 | 22 | 94 | 3 | M26929 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 4.49e-04 | 96 | 94 | 5 | MM14592 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR1_SIGNALING | 4.62e-04 | 23 | 94 | 3 | M27513 | |
| Pathway | KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY | 4.62e-04 | 23 | 94 | 3 | M47799 | |
| Pathway | REACTOME_RAS_PROCESSING | 5.25e-04 | 24 | 94 | 3 | M38995 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 5.89e-04 | 155 | 94 | 6 | M522 | |
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 5.22e-08 | 3 | 131 | 3 | 28116986 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 5.22e-08 | 3 | 131 | 3 | 37013448 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 5.22e-08 | 3 | 131 | 3 | 19101897 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 25977330 | ||
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 33620658 | ||
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 5.22e-08 | 3 | 131 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 5.22e-08 | 3 | 131 | 3 | 7776260 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 5.22e-08 | 3 | 131 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 5.22e-08 | 3 | 131 | 3 | 26253102 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 16573741 | ||
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 25788415 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 5.22e-08 | 3 | 131 | 3 | 20090846 | |
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 5.22e-08 | 3 | 131 | 3 | 26799184 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 21737741 | ||
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 5.22e-08 | 3 | 131 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 5.22e-08 | 3 | 131 | 3 | 23240926 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 17943694 | ||
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 5.22e-08 | 3 | 131 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 5.22e-08 | 3 | 131 | 3 | 17712732 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 24222113 | ||
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 5.22e-08 | 3 | 131 | 3 | 16761621 | |
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 5.22e-08 | 3 | 131 | 3 | 22945650 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 19303097 | ||
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 5.22e-08 | 3 | 131 | 3 | 20150643 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 20971740 | ||
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 27119512 | ||
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 5.22e-08 | 3 | 131 | 3 | 9334313 | |
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 2.08e-07 | 4 | 131 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 2.08e-07 | 4 | 131 | 3 | 29502968 | |
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 2.08e-07 | 4 | 131 | 3 | 7972015 | |
| Pubmed | 2.08e-07 | 4 | 131 | 3 | 10490827 | ||
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 2.08e-07 | 4 | 131 | 3 | 25999467 | |
| Pubmed | 2.08e-07 | 4 | 131 | 3 | 10085069 | ||
| Pubmed | 2.08e-07 | 4 | 131 | 3 | 38849523 | ||
| Pubmed | 2.08e-07 | 4 | 131 | 3 | 34948093 | ||
| Pubmed | 2.08e-07 | 4 | 131 | 3 | 9674433 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 2.08e-07 | 4 | 131 | 3 | 20080631 | |
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 2.08e-07 | 4 | 131 | 3 | 28117393 | |
| Pubmed | 5.19e-07 | 5 | 131 | 3 | 22982107 | ||
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 5.19e-07 | 5 | 131 | 3 | 34535655 | |
| Pubmed | 5.19e-07 | 5 | 131 | 3 | 9069260 | ||
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 5.19e-07 | 5 | 131 | 3 | 24746824 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 5.19e-07 | 5 | 131 | 3 | 15558479 | |
| Pubmed | 1.04e-06 | 6 | 131 | 3 | 9753431 | ||
| Pubmed | 1.04e-06 | 6 | 131 | 3 | 21072204 | ||
| Pubmed | 1.04e-06 | 6 | 131 | 3 | 10882715 | ||
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 1.04e-06 | 6 | 131 | 3 | 29615452 | |
| Pubmed | A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. | 1.04e-06 | 6 | 131 | 3 | 10893231 | |
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 1.04e-06 | 6 | 131 | 3 | 31337872 | |
| Pubmed | Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease. | 1.09e-06 | 21 | 131 | 4 | 27591083 | |
| Pubmed | 1.81e-06 | 7 | 131 | 3 | 19487299 | ||
| Pubmed | 1.81e-06 | 7 | 131 | 3 | 20526288 | ||
| Pubmed | 1.81e-06 | 7 | 131 | 3 | 20179099 | ||
| Pubmed | 1.81e-06 | 7 | 131 | 3 | 20012784 | ||
| Pubmed | 1.81e-06 | 7 | 131 | 3 | 9690470 | ||
| Pubmed | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | 1.81e-06 | 7 | 131 | 3 | 35904492 | |
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 1.81e-06 | 7 | 131 | 3 | 11948427 | |
| Pubmed | 1.81e-06 | 7 | 131 | 3 | 20860430 | ||
| Pubmed | 1.81e-06 | 7 | 131 | 3 | 22199277 | ||
| Pubmed | A2M FLNC TBX4 EXPH5 MORC4 DDB1 ZEB2 RNF14 FBN2 DST SUSD1 SMAD1 | 2.63e-06 | 591 | 131 | 12 | 15231748 | |
| Pubmed | 2.88e-06 | 8 | 131 | 3 | 15064703 | ||
| Pubmed | Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. | 2.88e-06 | 8 | 131 | 3 | 20150892 | |
| Pubmed | Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination. | 3.15e-06 | 27 | 131 | 4 | 30442762 | |
| Pubmed | 3.67e-06 | 28 | 131 | 4 | 20012529 | ||
| Pubmed | 4.31e-06 | 9 | 131 | 3 | 9344703 | ||
| Pubmed | 4.31e-06 | 9 | 131 | 3 | 10783161 | ||
| Pubmed | 4.31e-06 | 9 | 131 | 3 | 12482924 | ||
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 18514189 | ||
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 34215617 | ||
| Pubmed | Desmoplakin maintains gap junctions by inhibiting Ras/MAPK and lysosomal degradation of connexin-43. | 6.15e-06 | 10 | 131 | 3 | 29959233 | |
| Pubmed | SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. | 8.43e-06 | 11 | 131 | 3 | 28263956 | |
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 8.43e-06 | 11 | 131 | 3 | 8707838 | |
| Pubmed | 8.43e-06 | 11 | 131 | 3 | 10811835 | ||
| Pubmed | Current insights into the formation and breakdown of hemidesmosomes. | 8.43e-06 | 11 | 131 | 3 | 16757171 | |
| Pubmed | 1.12e-05 | 12 | 131 | 3 | 9269777 | ||
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 1.12e-05 | 12 | 131 | 3 | 9297626 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 19789336 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 16624289 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 27698462 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 24788728 | ||
| Pubmed | Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck. | 1.41e-05 | 2 | 131 | 2 | 31960612 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 23415882 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 1970154 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 20188103 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 33053566 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 33544116 | ||
| Pubmed | Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents. | 1.41e-05 | 2 | 131 | 2 | 14688017 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 20371679 | ||
| Pubmed | The prominent pervasive oncogenic role and tissue specific permissiveness of RAS gene mutations. | 1.41e-05 | 2 | 131 | 2 | 39455841 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 26049686 | ||
| Pubmed | Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients. | 1.41e-05 | 2 | 131 | 2 | 29921458 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 28939768 | ||
| Pubmed | Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia. | 1.41e-05 | 2 | 131 | 2 | 24737308 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 23978537 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 17210246 | ||
| Interaction | PPIAL4G interactions | 1.25e-06 | 30 | 129 | 5 | int:PPIAL4G | |
| Interaction | PPIAL4E interactions | 2.54e-06 | 5 | 129 | 3 | int:PPIAL4E | |
| Interaction | HEPH interactions | 5.05e-06 | 6 | 129 | 3 | int:HEPH | |
| Interaction | SEPTIN8 interactions | 2.02e-05 | 87 | 129 | 6 | int:SEPTIN8 | |
| Interaction | TMEM87A interactions | 2.77e-05 | 187 | 129 | 8 | int:TMEM87A | |
| Interaction | TRPV2 interactions | 2.98e-05 | 10 | 129 | 3 | int:TRPV2 | |
| Interaction | PPIAL4C interactions | 4.07e-05 | 11 | 129 | 3 | int:PPIAL4C | |
| Interaction | DEFA1 interactions | 4.46e-05 | 100 | 129 | 6 | int:DEFA1 | |
| Interaction | GTSF1 interactions | 5.40e-05 | 12 | 129 | 3 | int:GTSF1 | |
| Interaction | FBXO2 interactions | CACNA2D1 LAMA3 ITGA6 LAMP2 FBN2 COCH SUSD1 LRP2 COL14A1 TMEM131 SNX9 | 6.85e-05 | 411 | 129 | 11 | int:FBXO2 |
| Interaction | ZDHHC20 interactions | 8.05e-05 | 36 | 129 | 4 | int:ZDHHC20 | |
| Interaction | TMEM161A interactions | 8.62e-05 | 70 | 129 | 5 | int:TMEM161A | |
| Interaction | ITGB6 interactions | 8.86e-05 | 14 | 129 | 3 | int:ITGB6 | |
| Cytoband | 1q21.2 | 5.30e-05 | 71 | 131 | 4 | 1q21.2 | |
| Cytoband | 7q21-q22 | 3.58e-04 | 10 | 131 | 2 | 7q21-q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.11e-03 | 404 | 131 | 6 | chr1q21 | |
| Cytoband | 9q21.32 | 1.34e-03 | 19 | 131 | 2 | 9q21.32 | |
| Cytoband | 14q21.2 | 1.48e-03 | 20 | 131 | 2 | 14q21.2 | |
| Cytoband | 10p12.31 | 1.80e-03 | 22 | 131 | 2 | 10p12.31 | |
| Cytoband | 19p13 | 2.71e-03 | 27 | 131 | 2 | 19p13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF823 ZNF397 ZNF236 ZEB2 ZNF7 ZNF22 ZNF600 ZNF732 ZNF589 ZNF286B ZNF454 ZNF433 | 1.81e-04 | 718 | 88 | 12 | 28 |
| GeneFamily | RAS type GTPase family | 4.54e-04 | 31 | 88 | 3 | 389 | |
| GeneFamily | Fibronectin type III domain containing | 1.11e-03 | 160 | 88 | 5 | 555 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_200 | 1.15e-05 | 24 | 126 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#1_top-relative-expression-ranked_200 | 1.24e-05 | 86 | 126 | 6 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | CACNA2D1 FLNC ITGA6 LAMP2 CDK14 ZEB2 TULP2 FBN2 GUCY1A1 PTPRO LIPG ARHGAP29 KYAT3 COL14A1 ADGRE5 | 3.35e-05 | 740 | 126 | 15 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ZNF823 CACNA2D1 FLNC SDE2 LPAR4 CDK14 ZEB2 CNTN6 TULP2 FBN2 GUCY1A1 LIPG POC1B ARHGAP29 KYAT3 COL14A1 | 3.35e-05 | 831 | 126 | 16 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 5.64e-05 | 164 | 126 | 7 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-09 | 184 | 130 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-09 | 184 | 130 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-09 | 184 | 130 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.67e-07 | 169 | 130 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 187 | 130 | 7 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.86e-06 | 197 | 130 | 7 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.91e-06 | 153 | 130 | 6 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.91e-06 | 153 | 130 | 6 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-06 | 158 | 130 | 6 | 1cefb82b9bf79c687a119be568cfc15b14c6e040 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-06 | 160 | 130 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-06 | 160 | 130 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.91e-06 | 161 | 130 | 6 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.10e-06 | 165 | 130 | 6 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.01e-05 | 168 | 130 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 170 | 130 | 6 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 170 | 130 | 6 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 173 | 130 | 6 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 173 | 130 | 6 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 1.36e-05 | 177 | 130 | 6 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.64e-05 | 183 | 130 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-05 | 184 | 130 | 6 | 603faafb7b289a3c0242c84fc800c050c8a092ea | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-05 | 184 | 130 | 6 | c350504bfe0ec31cd2fc2199de9b5fff151a8c5e | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.80e-05 | 186 | 130 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 186 | 130 | 6 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.85e-05 | 187 | 130 | 6 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 187 | 130 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.91e-05 | 188 | 130 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 188 | 130 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-05 | 189 | 130 | 6 | cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-05 | 189 | 130 | 6 | 102501eee7760d5882dec41ea9d00147b3f4fb73 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.97e-05 | 189 | 130 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.97e-05 | 189 | 130 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 189 | 130 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-05 | 189 | 130 | 6 | 6e83bf855d4771885b60bb8992df2f9b508eef97 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.02e-05 | 190 | 130 | 6 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.09e-05 | 191 | 130 | 6 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-05 | 191 | 130 | 6 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.09e-05 | 191 | 130 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-05 | 192 | 130 | 6 | dc4b4e16e6eb212e45fb70695afd1c7e91027407 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-05 | 194 | 130 | 6 | 11ff53a748160570d2908ea9eb9779c038e5b676 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-05 | 194 | 130 | 6 | c992e3357f4bf3069f8d697803e5785e49a2ef0a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.28e-05 | 194 | 130 | 6 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | ASK440-Endothelial-Lymphatic|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.28e-05 | 194 | 130 | 6 | 4aa68e39e36094359dfbedf1e9bdf3ea5c32ed1a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.28e-05 | 194 | 130 | 6 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.34e-05 | 195 | 130 | 6 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.34e-05 | 195 | 130 | 6 | dc84a910b6f6eb9994cd683aa4fd813a82198e5f | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.34e-05 | 195 | 130 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 196 | 130 | 6 | a5cc4f76e1a3825aaccba9a686d7da6f7e4300ff | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 196 | 130 | 6 | 476812fc1422aca8010d771eff11fa6081f15a2d | |
| ToppCell | Control-Myeloid-DC2|Control / Condition, Lineage and Cell class | 2.41e-05 | 196 | 130 | 6 | 0ccc26c2811e4c8631e0abd8555b167ac1e7a982 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.48e-05 | 197 | 130 | 6 | 6852a8ec1397811bbdd1fc625c52ed4fa75a931e | |
| ToppCell | Control-Myeloid-DC2|Myeloid / Condition, Lineage and Cell class | 2.48e-05 | 197 | 130 | 6 | e0ee15188ff0d9df3c3b5ea523553ce18d223c33 | |
| ToppCell | Sepsis-URO-Others|URO / Disease, condition lineage and cell class | 2.55e-05 | 198 | 130 | 6 | 6caab5266da666cfbe92ac1ace26ad2004e5aa09 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 198 | 130 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Sepsis-URO-Others-RBC|URO / Disease, condition lineage and cell class | 2.55e-05 | 198 | 130 | 6 | d35e9d0952b3f7cd5d0d1a69bad2ae81af8eed50 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 198 | 130 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-05 | 198 | 130 | 6 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 198 | 130 | 6 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 199 | 130 | 6 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.63e-05 | 199 | 130 | 6 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.63e-05 | 199 | 130 | 6 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.63e-05 | 199 | 130 | 6 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.70e-05 | 200 | 130 | 6 | 5c0135d3cb6f7fa904e9760904dfe5f11c7e9102 | |
| ToppCell | proximal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.70e-05 | 200 | 130 | 6 | 870ab11343711f64fe6d6a858fc420fe17f1636a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.70e-05 | 200 | 130 | 6 | 22892afca3666e944102c231b3f10340d8391364 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.31e-05 | 138 | 130 | 5 | c172880eda7b8b8b758dbbc77f93191238f3181c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.50e-05 | 139 | 130 | 5 | 313f7e66ed94950129c7146a2afe2feb8951fe1e | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 5.69e-05 | 140 | 130 | 5 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 143 | 130 | 5 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.94e-05 | 146 | 130 | 5 | bee5074c29b132180d35f57d307e342efa9b8cd1 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.89e-05 | 150 | 130 | 5 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.78e-05 | 157 | 130 | 5 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-04 | 158 | 130 | 5 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 159 | 130 | 5 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 159 | 130 | 5 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-04 | 161 | 130 | 5 | 1670108afc0af90861eb80a84e59995571c0da1b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 161 | 130 | 5 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-04 | 161 | 130 | 5 | 1d446f5ba57d84949823a35cbedaee8f448fe40f | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lymph_Node / Location, Cell class and cell subclass | 1.13e-04 | 162 | 130 | 5 | 12bd0b99aee13da60d0684a5e2a705824db1899c | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-3|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.17e-04 | 163 | 130 | 5 | 0e8d3c98209fc98b86b841d69051cee9e276d837 | |
| ToppCell | Influenza_Severe-cDC|World / Disease group and Cell class | 1.20e-04 | 164 | 130 | 5 | c984228f73b9aa1aaf948541f64f41ed874770cd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_CYP26B1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 164 | 130 | 5 | 902cfdb8155bb2773aa69826d5b3b810a39c8d34 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.23e-04 | 165 | 130 | 5 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | Influenza_Severe-cDC|Influenza_Severe / Disease group and Cell class | 1.27e-04 | 166 | 130 | 5 | b40bdf0f7f381e25be61188e9f6c294d25a8b824 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 168 | 130 | 5 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 168 | 130 | 5 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 169 | 130 | 5 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 169 | 130 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_RSAD2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 170 | 130 | 5 | 63dfbc4746717132dc81b6bac868c7498fc96283 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 170 | 130 | 5 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 170 | 130 | 5 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-04 | 170 | 130 | 5 | 7bba77ae34a0259fad6ee98cf665ff50f77a1328 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.42e-04 | 170 | 130 | 5 | a43b977a7fe745536cf96b7c080397d9fa73086b | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.46e-04 | 171 | 130 | 5 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|normal_Lung / Location, Cell class and cell subclass | 1.54e-04 | 173 | 130 | 5 | e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330 | |
| ToppCell | ASK428-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.63e-04 | 175 | 130 | 5 | e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 175 | 130 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| Computational | Intermediate filaments. | 1.71e-04 | 75 | 75 | 5 | MODULE_154 | |
| Computational | Intermediate filaments and keratins. | 2.31e-04 | 80 | 75 | 5 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 2.31e-04 | 80 | 75 | 5 | MODULE_297 | |
| Drug | L 744832 | 6.44e-07 | 4 | 125 | 3 | ctd:C096898 | |
| Disease | Verrucous epidermal nevus | 7.07e-08 | 3 | 123 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 7.07e-08 | 3 | 123 | 3 | C4552097 | |
| Disease | Organoid Nevus Phakomatosis | 7.07e-08 | 3 | 123 | 3 | C0265329 | |
| Disease | Linear nevus sebaceous syndrome | 7.07e-08 | 3 | 123 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 7.07e-08 | 3 | 123 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 7.07e-08 | 3 | 123 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 7.07e-08 | 3 | 123 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 7.07e-08 | 3 | 123 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 7.07e-08 | 3 | 123 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Linear Verrucous Epidermal Nevus | 7.07e-08 | 3 | 123 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 7.07e-08 | 3 | 123 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | kidney cancer (implicated_via_orthology) | 9.27e-08 | 11 | 123 | 4 | DOID:263 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL (disorder) | 7.03e-07 | 5 | 123 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 7.03e-07 | 5 | 123 | 3 | C0206682 | |
| Disease | leukemia (implicated_via_orthology) | 1.06e-06 | 19 | 123 | 4 | DOID:1240 (implicated_via_orthology) | |
| Disease | Hemimegalencephaly | 1.40e-06 | 6 | 123 | 3 | C0431391 | |
| Disease | RASopathy (implicated_via_orthology) | 5.83e-06 | 9 | 123 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 6.30e-06 | 29 | 123 | 4 | DOID:11984 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 7.24e-06 | 30 | 123 | 4 | DOID:9256 (implicated_via_orthology) | |
| Disease | melanoma | 9.97e-06 | 248 | 123 | 8 | C0025202 | |
| Disease | Noonan Syndrome 1 | 1.14e-05 | 11 | 123 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 1.14e-05 | 11 | 123 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.14e-05 | 11 | 123 | 3 | C1527404 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 1.72e-05 | 2 | 123 | 2 | 614470 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 1.72e-05 | 2 | 123 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 1.72e-05 | 2 | 123 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 1.72e-05 | 2 | 123 | 2 | 137550 | |
| Disease | Melanocytic nevus | 1.72e-05 | 2 | 123 | 2 | cv:C0027962 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 1.72e-05 | 2 | 123 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 1.72e-05 | 2 | 123 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Large congenital melanocytic nevus | 1.72e-05 | 2 | 123 | 2 | cv:C1842036 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 1.96e-05 | 13 | 123 | 3 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | Papillary thyroid carcinoma | 3.08e-05 | 86 | 123 | 5 | C0238463 | |
| Disease | RASopathy | 3.10e-05 | 15 | 123 | 3 | cv:C5555857 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 5.16e-05 | 3 | 123 | 2 | C1842036 | |
| Disease | Adenocarcinoma of large intestine | 5.24e-05 | 96 | 123 | 5 | C1319315 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 6.52e-05 | 19 | 123 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 6.52e-05 | 19 | 123 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 6.52e-05 | 19 | 123 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 6.52e-05 | 19 | 123 | 3 | C0587248 | |
| Disease | BREAST CANCER | 8.90e-05 | 21 | 123 | 3 | 114480 | |
| Disease | LEOPARD Syndrome | 1.03e-04 | 22 | 123 | 3 | C0175704 | |
| Disease | NEVUS, EPIDERMAL | 1.03e-04 | 4 | 123 | 2 | 162900 | |
| Disease | Malignant neoplasm of penis | 1.03e-04 | 4 | 123 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 1.03e-04 | 4 | 123 | 2 | C0030849 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 1.03e-04 | 4 | 123 | 2 | C4011754 | |
| Disease | BLADDER CANCER | 1.03e-04 | 4 | 123 | 2 | 109800 | |
| Disease | Epidermal nevus | 1.03e-04 | 4 | 123 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 1.03e-04 | 4 | 123 | 2 | cv:C0005684 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 1.03e-04 | 4 | 123 | 2 | cv:C4225426 | |
| Disease | Malignant tumor of cervix | 1.03e-04 | 4 | 123 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 1.03e-04 | 4 | 123 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 1.03e-04 | 4 | 123 | 2 | 188470 | |
| Disease | Noonan Syndrome | 1.34e-04 | 24 | 123 | 3 | C0028326 | |
| Disease | cancer (implicated_via_orthology) | 1.37e-04 | 268 | 123 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | carcinoma (implicated_via_orthology) | 1.51e-04 | 64 | 123 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 1.71e-04 | 5 | 123 | 2 | C4225426 | |
| Disease | Epidermolysis Bullosa Simplex | 1.71e-04 | 5 | 123 | 2 | C0079298 | |
| Disease | Malignant neoplasm of thyroid | 1.71e-04 | 5 | 123 | 2 | C0007115 | |
| Disease | Cetuximab response | 1.71e-04 | 5 | 123 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 1.71e-04 | 5 | 123 | 2 | C0302592 | |
| Disease | Panitumumab response | 1.71e-04 | 5 | 123 | 2 | cv:CN077999 | |
| Disease | Malignant tumor of breast | 1.92e-04 | 27 | 123 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 1.92e-04 | 27 | 123 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 1.92e-04 | 27 | 123 | 3 | cv:C0346153 | |
| Disease | Pleocytosis | 2.56e-04 | 6 | 123 | 2 | C0151857 | |
| Disease | Autoimmune lymphoproliferative syndrome | 2.56e-04 | 6 | 123 | 2 | cv:CN301239 | |
| Disease | Carcinoma in situ of uterine cervix | 2.56e-04 | 6 | 123 | 2 | C0851140 | |
| Disease | seminoma (is_implicated_in) | 2.56e-04 | 6 | 123 | 2 | DOID:4440 (is_implicated_in) | |
| Disease | Leukocytosis | 2.56e-04 | 6 | 123 | 2 | C0023518 | |
| Disease | intestinal cancer (implicated_via_orthology) | 3.21e-04 | 32 | 123 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | aggressive behaviour measurement, childhood aggressive behaviour measurement | 3.21e-04 | 32 | 123 | 3 | EFO_0007663, EFO_0007826 | |
| Disease | prostate cancer (implicated_via_orthology) | 3.52e-04 | 33 | 123 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 3.57e-04 | 7 | 123 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Thyroid cancer, follicular | 3.57e-04 | 7 | 123 | 2 | C2931367 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 3.57e-04 | 7 | 123 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Colonic Neoplasms | 4.50e-04 | 152 | 123 | 5 | C0009375 | |
| Disease | Alzheimer's disease biomarker measurement, brain volume measurement | 4.75e-04 | 8 | 123 | 2 | EFO_0006514, EFO_0006930 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 4.75e-04 | 8 | 123 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | Thyroid Neoplasm | 4.95e-04 | 37 | 123 | 3 | C0040136 | |
| Disease | heart disease (implicated_via_orthology) | 5.36e-04 | 38 | 123 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Malignant tumor of colon | 5.53e-04 | 159 | 123 | 5 | C0007102 | |
| Disease | Idiopathic pulmonary hypertension | 6.09e-04 | 9 | 123 | 2 | C0152171 | |
| Disease | Hepatocellular Adenoma | 6.09e-04 | 9 | 123 | 2 | C0206669 | |
| Disease | Noonan syndrome | 6.09e-04 | 9 | 123 | 2 | cv:C0028326 | |
| Disease | Lymphoma | 6.24e-04 | 40 | 123 | 3 | C0024299 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 6.71e-04 | 41 | 123 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 6.71e-04 | 41 | 123 | 3 | C0858252 | |
| Disease | Colorectal Carcinoma | 7.34e-04 | 702 | 123 | 10 | C0009402 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 7.59e-04 | 10 | 123 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | Leukemia, Myelocytic, Acute | 8.09e-04 | 173 | 123 | 5 | C0023467 | |
| Disease | cognitive impairment measurement | 8.26e-04 | 44 | 123 | 3 | EFO_0007998 | |
| Disease | high grade glioma (implicated_via_orthology) | 8.26e-04 | 44 | 123 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Thyroid carcinoma | 8.26e-04 | 44 | 123 | 3 | C0549473 | |
| Disease | Adenoid Cystic Carcinoma | 8.28e-04 | 100 | 123 | 4 | C0010606 | |
| Disease | Gastric Adenocarcinoma | 8.83e-04 | 45 | 123 | 3 | C0278701 | |
| Disease | entorhinal cortical volume, Alzheimer's disease biomarker measurement | 9.25e-04 | 11 | 123 | 2 | EFO_0005092, EFO_0006514 | |
| Disease | Neuroblastoma | 1.00e-03 | 47 | 123 | 3 | C0027819 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 1.30e-03 | 13 | 123 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | Liver carcinoma | 1.32e-03 | 507 | 123 | 8 | C2239176 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVFTGKQDTVQCFSC | 186 | Q13075 | |
| NVTLTCNGNNFFEVS | 46 | P12319 | |
| DASKVFNNTGCLFFS | 416 | Q9H172 | |
| SKASSFNESGSQCFV | 376 | Q8IZF5 | |
| ATNQSKCFGFVSFDN | 416 | Q5SZQ8 | |
| KVIEAYCTSANFQQG | 661 | Q15052 | |
| STKQCQTSALFQFAE | 261 | Q8WY36 | |
| GSEFNLNDVVNFTCN | 2751 | Q96PZ7 | |
| SVKNGDSSNDFVTCN | 411 | Q6ULP2 | |
| QCGKVAFQFQCSSDS | 506 | Q96KE9 | |
| SQGFEFFCSQSLSKN | 236 | Q8NHS2 | |
| SGAKTFKNESENTCQ | 101 | P48960 | |
| SFLSSNSTFCNKQNV | 3866 | Q8TCU4 | |
| TGLASCAANSINQFF | 196 | Q12887 | |
| ENNACINFKTSSTGK | 96 | O94921 | |
| RATNQSKCFGFVSFD | 431 | Q96J87 | |
| VINFDGATTLKNFCS | 321 | P59510 | |
| EDSQAFCEKFSGQLN | 281 | P01023 | |
| TNSADASSNKFVFGQ | 311 | Q9H6Z4 | |
| EGFLCVFAINNTKSF | 76 | P01112 | |
| EGFLCVFAINNTKSF | 76 | P01116 | |
| EGFLCVFAINNSKSF | 76 | P01111 | |
| EFNFLKCSEQLSSGQ | 761 | Q9UN71 | |
| QFLDFGSVNACEKTS | 61 | Q15118 | |
| AGLQAFFQVQECNKS | 346 | P00450 | |
| NTNGSQFFICTAKTE | 106 | A0A0B4J2A2 | |
| VTAFTLSFCGNNEIN | 161 | Q8NGE9 | |
| QGNRINEFSISSFCT | 321 | Q06828 | |
| TNSFVGCLKNFQLDS | 3121 | Q16787 | |
| ITNKCEEFFSQAAAS | 1126 | Q03001 | |
| VNNATTTCFEGFSKR | 181 | Q99677 | |
| ECQFTNKSTSSLAGN | 926 | Q8IYD8 | |
| FCKTAFDISIDNGNE | 136 | Q06547 | |
| FGKNSTQDEVYNTCI | 51 | Q86VH2 | |
| ACTQPAKTTAFFQGN | 651 | A6NKB5 | |
| EQKTISFVGCAAQFF | 91 | Q8NGJ0 | |
| NFGQLEENFLSSSCQ | 461 | Q8NEN9 | |
| SQAFVGQKNSFTVDC | 2646 | Q14315 | |
| VNQDKPSFAFQCTDS | 286 | Q9Y5X9 | |
| VQKNTFGSTSLCFDS | 311 | Q8NEV8 | |
| NVTQGKYSTAQDCSA | 356 | P13473 | |
| KSYDVNIQTGSNACN | 961 | P98164 | |
| QSDGKNCAISTENFL | 2376 | P98164 | |
| GSCQQGVAATFTKDF | 186 | P23229 | |
| KQCVNNFSDSVGFAN | 176 | Q8TC44 | |
| NTNGSQFFICAAKTE | 106 | P0DN26 | |
| GAVANKLCQSFQTFS | 331 | P31930 | |
| AGFNSSIFSVFKDQQ | 1011 | Q6ZV29 | |
| ISFCKALQVADFSGN | 101 | Q9BTT6 | |
| NTNGSQFFICAAKTE | 106 | A0A075B759 | |
| KPEEGSFCSNSQVAF | 21 | Q7Z442 | |
| DNAQNFSFKTNSGFA | 241 | O15504 | |
| FFEVFCQQVGSSQKT | 751 | Q16827 | |
| KGRNLCATFQNTETF | 656 | Q9BX63 | |
| NTNGSQFFICAAKTE | 106 | F5H284 | |
| SSAGCNNFSFTQKIQ | 921 | Q9UHC9 | |
| FNSTLAQQGTESFQC | 26 | Q5VYJ5 | |
| NTNGSQFFICAAKTE | 106 | Q9Y536 | |
| NTNGSQFFICTAKTE | 106 | P0DN37 | |
| AATTVCSKFNGFDQQ | 1061 | Q52LW3 | |
| DFNLQNSSGCEKDFV | 2381 | O60494 | |
| FQIKQYNSVSCGVSE | 2276 | Q13315 | |
| INTGKFTFSFQAQLC | 4231 | Q4G0P3 | |
| FIGVNCLSTDFSSQK | 351 | Q8TE85 | |
| SLFQFSNCSQGQQLA | 156 | Q9BQI4 | |
| ACANKGFFTQISTLA | 411 | Q8IZS8 | |
| VASFNSNAQDVSCFQ | 291 | P54289 | |
| NVKIFASQASGFSDA | 896 | Q05707 | |
| ATNQSKCFGFVSFDN | 436 | Q8N6W0 | |
| FSCFQKAQLKSANTG | 76 | Q9HBE4 | |
| NTFQEFFGLSNCEST | 266 | P41597 | |
| SYTCIATNQFGTAKN | 476 | Q9UQ52 | |
| SQQLFSSCTAKFADG | 476 | Q53TQ3 | |
| INSTNFCTSAKDAFV | 506 | Q8WWI5 | |
| NVIQAKFFPNCGDST | 241 | A6NGE4 | |
| QSFCFTNFENGKCSV | 2101 | P35556 | |
| LGSNSDAQAKCQAFQ | 396 | Q6UWW8 | |
| TFVDKAVCRNNGFFS | 316 | O43405 | |
| GCQAQVTFNFTSFKS | 61 | P60507 | |
| NFFVKCNGALINTSD | 46 | Q6IQ49 | |
| NRQNSTGKACFGTFL | 71 | Q9NRP4 | |
| AFNLFVCQKDSAATT | 971 | Q16531 | |
| PVSAFCNSETKSQFE | 411 | Q6YP21 | |
| QAGQVFENFVQASTC | 11 | O94851 | |
| FENFVQASTCKGTLQ | 16 | O94851 | |
| VFLSCFSQFTEQGNK | 821 | Q9Y6K5 | |
| SNTAEDKFVFCNGLV | 486 | Q92570 | |
| DQFSCGNSVADQAFL | 66 | Q9Y5X1 | |
| NTNGSQFFICTAKTE | 106 | P62937 | |
| KQNFVLACISFFTGA | 106 | P0DP42 | |
| CGEFSKAAQSFSNAL | 26 | Q96NG3 | |
| NVSCNIFINSFGSIA | 66 | P23415 | |
| QDNFSKFGLCTFSDV | 966 | O15197 | |
| CDSKGFTNISQITEF | 61 | O94933 | |
| VRITFGFSCKNSNQF | 316 | Q8TE76 | |
| CDETQETGSFSKFVN | 221 | Q9UK23 | |
| SFFNAGTFREEQKCT | 3381 | P08F94 | |
| NKSDFACANAFNNSI | 66 | P01848 | |
| SGCSLKIFNNQEFAQ | 376 | Q15797 | |
| SSCISNKFANDGSFL | 76 | Q8IWZ8 | |
| FKIFVSGNSNECLQN | 46 | Q9UBS8 | |
| CQCGKAFSDLSSFQN | 446 | P16415 | |
| NVFSTKFTIFDNGVN | 356 | O00295 | |
| ECGKAFNQFSQLTTH | 426 | A8MTY0 | |
| FQCNESGKAFNCSSL | 6 | Q9H963 | |
| QCLSQADAFFKAAIS | 736 | Q7Z3J2 | |
| KGLSNLGNTCFFNAV | 196 | Q9Y5T5 | |
| NKSDFACANAFNNSI | 201 | P0DTU3 | |
| TKSCSQQAIFVGQNY | 1471 | Q6ZQQ2 | |
| NNKTFIPNDGTFCTD | 111 | Q6UWL2 | |
| FKVVNCQEFTLSANA | 1046 | Q92545 | |
| SFACENNDFLVTDGK | 501 | P08922 | |
| SGFGFINSENVFKVC | 241 | P35250 | |
| NKASECFQQAFDTTV | 371 | Q8NA56 | |
| FKQNGSTQSCQELFR | 36 | Q8NF99 | |
| ADCGKSFFQSSNLIQ | 86 | P17026 | |
| NECGKAFNQSTSFLQ | 331 | Q8N9F8 | |
| AFCPAAFSQKGNLQS | 256 | Q9UL36 | |
| TGSFQKAKFNITGAC | 571 | Q9UPP1 | |
| CSECGKTFSQSSNFA | 441 | P0CG31 | |
| ADENNAFGSKNTAFC | 201 | P57082 | |
| FGSKTQQTFGSQTEC | 786 | Q9Y4F4 | |
| EECGNIFTTSSNFAK | 226 | B4DXR9 | |
| TFGECALAFNQKSNL | 216 | Q86UQ0 | |
| NNGTVKNANCTSDFE | 131 | O60315 | |
| SFQCNESGKAFNCSS | 161 | Q6ZNG1 | |
| CNQCGKAFNSSSSFR | 396 | Q8N7K0 | |
| LSNKDCFNLIAFGST | 541 | A6NCI4 | |
| QNCSELFKTQTFSGD | 126 | Q8NBN3 | |
| NECGKAFSQNSTLFQ | 556 | P17097 | |
| LFGNNVTLANKFESC | 596 | Q02108 | |
| FACGRAKETNNSFQE | 106 | P23276 | |
| TEFENFQKSCDGSQI | 1136 | Q86UW6 |